This website is intended for healthcare professionals only.

Hospital Healthcare Europe
Hospital Pharmacy Europe     Newsletter       

Clinical

18
Autonomic Technologies® supports first Cluster Headache Day to raise awareness
Autonomic Technologies® supports first Cluster Headache Day to raise awareness
Read more
LEO Pharma receives EU scientific approval of Enstilar® for the treatment of psoriasis
LEO Pharma receives EU scientific approval of Enstilar® for the treatment of psoriasis
Read more
Survival benefit shown in men with early and less aggressive mCRPC treated with Zytiga® plus prednisone
Survival benefit shown in men with early and less aggressive mCRPC treated with Zytiga® plus prednisone
Read more
Brussels Declaration on ADPKD one year on: progress in the fight against a devastating kidney disease
Brussels Declaration on ADPKD one year on: progress in the fight against a devastating kidney disease
Read more
Novartis’ Cosentyx® superior to Stelara in delivering lasting skin clearance for psoriasis patients
Novartis’ Cosentyx® superior to Stelara in delivering lasting skin clearance for psoriasis patients
Read more
First European hospital undergoes Continuity of Care evaluation by HIMSS Analytics team
First European hospital undergoes Continuity of Care evaluation by HIMSS Analytics team
Read more
SMC accepts breakthrough treatment Entresto™ for symptomatic chronic heart failure
SMC accepts breakthrough treatment Entresto™ for symptomatic chronic heart failure
Read more
HIMSS Analytics and ESR launch diagnostic imaging adoption model
HIMSS Analytics and ESR launch diagnostic imaging adoption model
Read more
Merck initiates Phase III study of MSB11022 in chronic plaque psoriasis
Merck initiates Phase III study of MSB11022 in chronic plaque psoriasis
Read more
Allergan completes transfer of European MA for Ironwood’s Constella® from Almirall S.A
Allergan completes transfer of European MA for Ironwood’s Constella® from Almirall S.A
Read more
ProStrakan and AstraZeneca enter into agreement for rights to Moventig® in Europe
ProStrakan and AstraZeneca enter into agreement for rights to Moventig® in Europe
Read more
Boehringer Ingelheim UK launches two new initiatives to support people living with IPF
Boehringer Ingelheim UK launches two new initiatives to support people living with IPF
Read more
Campaign to reduce delay in diagnosis for people with axial spondyloarthritis
Campaign to reduce delay in diagnosis for people with axial spondyloarthritis
Read more
Briviact® launches in the UK, offering a new option for patients with uncontrolled epilepsy
Briviact® launches in the UK, offering a new option for patients with uncontrolled epilepsy
Read more
Sobi and Biogen receive positive opinion from CHMP for Alprolix® for the treatment of haemophilia B
Sobi and Biogen receive positive opinion from CHMP for Alprolix® for the treatment of haemophilia B
Read more
CPI and Cobra Biologics announce collaboration for development of regenerative medicines
CPI and Cobra Biologics announce collaboration for development of regenerative medicines
Read more
Peterborough and Stamford Hospitals to tackle A&E targets with new analytics tool
Peterborough and Stamford Hospitals to tackle A&E targets with new analytics tool
Read more
Global tech exclusivity boosts growth plans at Crawford Healthcare
Global tech exclusivity boosts growth plans at Crawford Healthcare
Read more

Popular articles

Genomic data and technology set to power NHS 10-year plan
New NHS operating model and financial incentives explained
Cardiology, respiratory and dermatology to be prioritised in NHS technology expansion
Can plastic waste really be turned into sustainable paracetamol?
Personalised care plans for majority of complex patients within two years, says Government



 
FOLLOW US

IMPORTANT LINKS

MORE FROM COGORA

© Cogora 2025
Cogora Limited. 1 Giltspur Street, London EC1A 9DD Registered in the United Kingdom. Reg. No. 2147432

Cogora
x